Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DelotaSYDRF 18 EV-to-EBITDA is 2.84 as of Jul. 29, 2026, which is 47% above its 10-year median of 1.93. GuruFocus rates SYDRF with a GF Score™ of 18/100 and a GF Value™ of $0.17. The stock has 4 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Delota ranks better than 95.09% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Delota's enterprise value is $4.33 Mil.
Delota's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $1.52 Mil. Therefore, Delota's EV-to-EBITDA for today is 2.84.
The historical rank and industry rank for Delota's EV-to-EBITDA or its related term are showing as below:
SYDRF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -60.81 Med: 1.93 Max: 12.06
Current: 2.72
During the past 11 years, the highest EV-to-EBITDA of Delota was 12.06. The lowest was -60.81. And the median was 1.93.
SYDRF's EV-to-EBITDA is ranked better than 95.09% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.14
vs SYDRF: 2.72
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Delota (OTCPK:SYDRF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Delota's share price for today is $0.10.
Delota's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Delota's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Delota's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delota EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Delota's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Delota's EV-to-EBITDA falls into.
Delota's current Enterprise Value is $4.33 Mil.
Delota's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delota (SYDRF) has a EV-to-EBITDA of 2.84 as of Jul. 29, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Delota. This is 47% above median its historical median of 1.93. According to the industry distribution chart, Delota ranks #25 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 4.9%.
Is Delota's EV-to-EBITDA too high?
Delota's current EV-to-EBITDA of 2.84 is 47% above median its 10-year median of 1.93. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.14. Delota's value of 2.84 is 74.5% below this industry median. Based on the distribution chart, Delota ranks #25 out of 509 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Delota has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Delota's EV-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Delota ranks #25 out of 509 companies for EV-to-EBITDA. This places Delota in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 11.14. Delota's value of 2.84 is 74.5% below this benchmark. While the company's 10-year median is 1.93 vs. the industry median of 11.14, Delota has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.14, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delota's current EV-to-EBITDA of 2.84 is 74.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Delota. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delota's current EV-to-EBITDA is 2.84, which is 47% above median its own 10-year median of 1.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delota stock overvalued right now?
Delota (SYDRF) has a current EV-to-EBITDA of 2.84. The stock's GF Value™ is $0.17, compared to a current price of $0.10 — trading 41.2% below its estimated fair value. The current EV-to-EBITDA is 2.84, which is 47% above median its 10-year median of 1.93 and 74.5% below the Healthcare Providers & Services industry median of 11.14. Delota's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Delota (SYDRF), the current EV-to-EBITDA is 2.84 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Delota (SYDRF) Overvalued in 2026?
Based on GuruFocus' analysis, Delota stock appears to be undervalued.
The current stock price of $0.10 is trading 41.2% below its estimated GF Value™ of $0.17.
Key valuation signals for SYDRF:
EV-to-EBITDA: 2.84 (47% above median its 10-year median of 1.93)
GF Value™: $0.17 vs. price of $0.10 (41.2% below fair value)
Industry Position: 74.5% below the Healthcare Providers & Services median (#25 of 509)
No single metric tells the full story. See the SYDRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Delota Corp is a cannabis and nicotine retailer. The company is engaged in developing retail cannabis and nicotine brands in Canada by growing its retail footprint and developing retail banners. The Company's flagship brand, one hundred eighty Smoke Vape Store, stands as Ontario's omni channel specialty vape retailer, fueling innovation, growth, and leadership in the nicotine vape and alternative tobacco sector. The Company operates twenty nine brick-and-mortar specialty vape stores in Ontario under the one hundred eighty Smoke Vape Store brand, a dominant national e-commerce platform and three licensed dispensaries in Ontario under the Offside Cannabis brand.
18GF Score
Get the complete analysis for SYDRF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SYDRF has been successfully added to your 
